Inhibition of vascular smooth muscle cell proliferation by ribozymes that cleave c-myb mRNA.
Proliferation of injured smooth muscle cells contributes to the reocclusion or restenosis of coronary arteries that often occurs following angioplasty procedures. We have identified and optimized nuclease-resistant ribozymes that efficiently cleave c-myb RNA. Three ribozymes targeting different sites in the c-myb mRNA were synthesized chemically and delivered to rat aortic smooth muscle cells with cationic lipids; all three inhibited serum-stimulated cell proliferation significantly. RNA molecules with two base substitutions in the catalytic core that render the ribozyme catalytically inactive had little effect on smooth muscle cell proliferation. Ribozymes with scrambled binding arm sequences also failed to affect cell cycle progression of vascular smooth muscle cells. Furthermore, inhibition of rat smooth muscle cell proliferation correlated with a reduction in intact c-myb mRNA. Efficacy of the chemically-modified ribozyme was compared directly to phosphorothioate antisense oligodeoxynucleotides targeting the same site in the c-myb RNA; the ribozyme had superior efficacy and showed greater specificity than the antisense molecules. Exogenously delivered ribozymes also inhibited porcine and human smooth muscle cell proliferation effectively. Ribozymes targeting c-myb or other regulators of smooth muscle cell proliferation may represent novel therapeutics for the treatment of restenosis after coronary angioplasty.
Jarvis
T C
TC
Ribozyme Pharmaceuticals, Inc., Boulder, Colorado 80301, USA. tjarvis@rpi.com
Alby
L J
LJ
Beaudry
A A
AA
Wincott
F E
FE
Beigelman
L
L
McSwiggen
J A
JA
Usman
N
N
Stinchcomb
D T
DT
D000818:Animals; D001011:Aorta; D001483:Base Sequence; D002455:Cell Division; D002478:Cells, Cultured; D017931:DNA Primers; D005260:Female; D006801:Humans; D008969:Molecular Sequence Data; D009131:Muscle, Smooth, Vascular / Q000166:cytology*; D009690:Nucleic Acid Conformation; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D020598:Proto-Oncogene Proteins c-myb; D016337:RNA, Catalytic / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013552:Swine; D015534:Trans-Activators / Q000235:genetics*
D017931:DNA Primers; D011518:Proto-Oncogene Proteins; D020598:Proto-Oncogene Proteins c-myb; D016337:RNA, Catalytic; D012333:RNA, Messenger; D015534:Trans-Activators